Improving LNP Potency Assay Robustness to Enable Reliable QC Transfer

• Understanding regulatory expectations shaping potency assay design and validation
• Anticipating transfer requirements when developing mRNA LNP assays for future QC
• use
• Comparing base and targeted LNP approaches to inform robust assay development

Speakers:

Benjamin Hall

Associate Director, Analytical Development

Tessera Therapeutics